Przejdź do
SML2707
TAS-102
≥98% (HPLC)
Synonim(y):
2′-Deoxy-5-trifluoromethyluridine for Trifluridine, Lonsurf, Tipiracil hydrochloride-trifluridine mixt, Trifluridine/Tipiracil HCl
Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.
Wybierz wielkość
Zmień widok
| Do Państwa/SKU | Dostępność | Cena netto |
|---|---|---|
10 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 593,00 zł |
Informacje o tej pozycji
NACRES:
NA.77
UNSPSC Code:
12352200
Assay:
≥98% (HPLC)
Form:
powder
593,00 zł
Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomócQuality Segment
assay
≥98% (HPLC)
form
powder
solubility
DMSO: 100 mg/mL, H2O: 15 mg/mL
storage temp.
2-8°C
General description
TAS-102 is a combination of two active ingredients: trifluridine (TFT), a nucleoside analog, and tipiracil (TPI), a thymidine phosphorylase inhibitor in a 1.0:0.5 molar ratio (TFT:TPI).1 TFT is the active antitumor component of TAS-102, its monophosphate form inhibits thymidylate synthase, an enzyme that plays a main role in DNA synthesis, and its triphosphate form is incorporated into DNA in tumor cells resulting in DNA dysfunction. TPI increases the bioavailability of TFT that is rapidly degraded to its inactive form by thymidine phosphorylase in the intestines and liver. The formulation presents a double targeted due to the cytotoxic effect of TFT, which is enhanced by TPI, while TPI also exerts antiangiogenic effects by inhibiting thymidine phosphorylase.2 TAS 102 inhibits KM20C colon cancer xenograft growth by 70.5% when was orally administered twice daily at a dose of 150 mg/kg for 14 days.3 TAS-102 has great potential to improve the treatment of malignancies when combined with other angiostatic or cytotoxic agents. A combination of TAS-102 and Avastin, an antineoplastic agent, was found to increase chemotherapeutic efficacy against colorectal cancer xenograft, compared with that for either drug alone.4
Biochem/physiol Actions
Anti cancer, Anti angiogenic
Other Notes
Solubility:DMSO 100 mg/mL; water 15mg/ml
TAS-102 is a mixture of 2 components. In order to maintain the original ratio between the components, the entire content of vial needs to be solubilized.
TAS-102 is a mixture of 2 components. In order to maintain the original ratio between the components, the entire content of vial needs to be solubilized.
Ta strona może zawierać tekst przetłumaczony maszynowo.
1 of 1
Ta pozycja | |||
|---|---|---|---|
| form powder | form powder | form lyophilized | form powder |
| assay ≥98% (HPLC) | assay ≥99% (HPLC) | assay ≥98% (HPLC) | assay ≥99% (HPLC) |
| Quality Level 100 | Quality Level 200 | Quality Level 200 | Quality Level 100 |
| storage temp. 2-8°C | storage temp. room temp | storage temp. 2-8°C | storage temp. −20°C |
| solubility DMSO: 100 mg/mL, H2O: 15 mg/mL | solubility water: 50 mg/mL, clear, colorless to faintly yellow | solubility methanol: 1 mg/mL, 50% acetic acid: 25 mg/mL, DMSO: 25 mg/mL | solubility water: 50 mg/mL, clear, colorless |
signalword
Warning
hcodes
pcodes
Hazard Classifications
Carc. 2 - Muta. 2 - Repr. 2
Klasa składowania
11 - Combustible Solids
wgk
WGK 3
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.